FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074784562> ?p ?o ?g. }

• W2074784562 endingPage "28539" @default.
• W2074784562 startingPage "28529" @default.
• W2074784562 abstract "Ferlins are an ancient family of C2 domain-containing proteins, with emerging roles in vesicular trafficking and human disease. Dysferlin mutations cause inherited muscular dystrophy, and dysferlin also shows abnormal plasma membrane expression in other forms of muscular dystrophy. We establish dysferlin as a short-lived (protein half-life ∼4–6 h) and transitory transmembrane protein (plasma membrane half-life ∼3 h), with a propensity for rapid endocytosis when mutated, and an association with a syntaxin-4 endocytic route. Dysferlin plasma membrane expression and endocytic rate is regulated by the C2B-FerI-C2C motif, with a critical role identified for C2C. Disruption of C2C dramatically reduces plasma membrane dysferlin (by 2.5-fold), due largely to accelerated endocytosis (by 2.5-fold). These properties of reduced efficiency of plasma membrane expression due to accelerated endocytosis are also a feature of patient missense mutant L344P (within FerI, adjacent to C2C). Importantly, dysferlin mutants that demonstrate accelerated endocytosis also display increased protein lability via endosomal proteolysis, implicating endosomal-mediated proteolytic degradation as a novel basis for dysferlin-deficiency in patients with single missense mutations. Vesicular labeling studies establish that dysferlin mutants rapidly transit from EEA1-positive early endosomes through to dextran-positive lysosomes, co-labeled by syntaxin-4 at multiple stages of endosomal transit. In summary, our studies define a transient biology for dysferlin, relevant to emerging patient therapeutics targeting dysferlin replacement. We introduce accelerated endosomal-directed degradation as a basis for lability of dysferlin missense mutants in dysferlinopathy, and show that dysferlin and syntaxin-4 similarly transit a common endosomal pathway in skeletal muscle cells. Ferlins are an ancient family of C2 domain-containing proteins, with emerging roles in vesicular trafficking and human disease. Dysferlin mutations cause inherited muscular dystrophy, and dysferlin also shows abnormal plasma membrane expression in other forms of muscular dystrophy. We establish dysferlin as a short-lived (protein half-life ∼4–6 h) and transitory transmembrane protein (plasma membrane half-life ∼3 h), with a propensity for rapid endocytosis when mutated, and an association with a syntaxin-4 endocytic route. Dysferlin plasma membrane expression and endocytic rate is regulated by the C2B-FerI-C2C motif, with a critical role identified for C2C. Disruption of C2C dramatically reduces plasma membrane dysferlin (by 2.5-fold), due largely to accelerated endocytosis (by 2.5-fold). These properties of reduced efficiency of plasma membrane expression due to accelerated endocytosis are also a feature of patient missense mutant L344P (within FerI, adjacent to C2C). Importantly, dysferlin mutants that demonstrate accelerated endocytosis also display increased protein lability via endosomal proteolysis, implicating endosomal-mediated proteolytic degradation as a novel basis for dysferlin-deficiency in patients with single missense mutations. Vesicular labeling studies establish that dysferlin mutants rapidly transit from EEA1-positive early endosomes through to dextran-positive lysosomes, co-labeled by syntaxin-4 at multiple stages of endosomal transit. In summary, our studies define a transient biology for dysferlin, relevant to emerging patient therapeutics targeting dysferlin replacement. We introduce accelerated endosomal-directed degradation as a basis for lability of dysferlin missense mutants in dysferlinopathy, and show that dysferlin and syntaxin-4 similarly transit a common endosomal pathway in skeletal muscle cells." @default.
• W2074784562 created "2016-06-24" @default.
• W2074784562 creator A5003438809 @default.
• W2074784562 creator A5008811325 @default.
• W2074784562 creator A5012291321 @default.
• W2074784562 creator A5013454515 @default.
• W2074784562 creator A5015504090 @default.
• W2074784562 creator A5029211283 @default.
• W2074784562 creator A5053165850 @default.
• W2074784562 creator A5056193115 @default.
• W2074784562 creator A5062702921 @default.
• W2074784562 date "2010-09-01" @default.
• W2074784562 modified "2023-10-16" @default.
• W2074784562 title "Reduced Plasma Membrane Expression of Dysferlin Mutants Is Attributed to Accelerated Endocytosis via a Syntaxin-4-associated Pathway" @default.
• W2074784562 cites W1551910894 @default.
• W2074784562 cites W1563834930 @default.
• W2074784562 cites W1592698849 @default.
• W2074784562 cites W1779934359 @default.
• W2074784562 cites W1809106246 @default.
• W2074784562 cites W1964162087 @default.
• W2074784562 cites W1964383093 @default.
• W2074784562 cites W1982630258 @default.
• W2074784562 cites W1991180491 @default.
• W2074784562 cites W1997874647 @default.
• W2074784562 cites W1999477428 @default.
• W2074784562 cites W2008146383 @default.
• W2074784562 cites W2013898345 @default.
• W2074784562 cites W2028665411 @default.
• W2074784562 cites W2036467191 @default.
• W2074784562 cites W2043172254 @default.
• W2074784562 cites W2047136624 @default.
• W2074784562 cites W2052373139 @default.
• W2074784562 cites W2054907554 @default.
• W2074784562 cites W2056293200 @default.
• W2074784562 cites W2062899296 @default.
• W2074784562 cites W2071320656 @default.
• W2074784562 cites W2071457689 @default.
• W2074784562 cites W2078577861 @default.
• W2074784562 cites W2081225557 @default.
• W2074784562 cites W2084392338 @default.
• W2074784562 cites W2085639974 @default.
• W2074784562 cites W2095117681 @default.
• W2074784562 cites W2097880588 @default.
• W2074784562 cites W2105788894 @default.
• W2074784562 cites W2112697515 @default.
• W2074784562 cites W2116629782 @default.
• W2074784562 cites W2118881578 @default.
• W2074784562 cites W2119866943 @default.
• W2074784562 cites W2122524549 @default.
• W2074784562 cites W2137392137 @default.
• W2074784562 cites W2150158001 @default.
• W2074784562 cites W2154472809 @default.
• W2074784562 cites W2155132039 @default.
• W2074784562 cites W2159164732 @default.
• W2074784562 cites W2161549226 @default.
• W2074784562 doi "https://doi.org/10.1074/jbc.m110.111120" @default.
• W2074784562 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2937879" @default.
• W2074784562 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20595382" @default.
• W2074784562 hasPublicationYear "2010" @default.
• W2074784562 type Work @default.
• W2074784562 sameAs 2074784562 @default.
• W2074784562 citedByCount "39" @default.
• W2074784562 countsByYear W20747845622012 @default.
• W2074784562 countsByYear W20747845622013 @default.
• W2074784562 countsByYear W20747845622014 @default.
• W2074784562 countsByYear W20747845622015 @default.
• W2074784562 countsByYear W20747845622016 @default.
• W2074784562 countsByYear W20747845622017 @default.
• W2074784562 countsByYear W20747845622018 @default.
• W2074784562 countsByYear W20747845622020 @default.
• W2074784562 countsByYear W20747845622022 @default.
• W2074784562 countsByYear W20747845622023 @default.
• W2074784562 crossrefType "journal-article" @default.
• W2074784562 hasAuthorship W2074784562A5003438809 @default.
• W2074784562 hasAuthorship W2074784562A5008811325 @default.
• W2074784562 hasAuthorship W2074784562A5012291321 @default.
• W2074784562 hasAuthorship W2074784562A5013454515 @default.
• W2074784562 hasAuthorship W2074784562A5015504090 @default.
• W2074784562 hasAuthorship W2074784562A5029211283 @default.
• W2074784562 hasAuthorship W2074784562A5053165850 @default.
• W2074784562 hasAuthorship W2074784562A5056193115 @default.
• W2074784562 hasAuthorship W2074784562A5062702921 @default.
• W2074784562 hasBestOaLocation W20747845621 @default.
• W2074784562 hasConcept C102747710 @default.
• W2074784562 hasConcept C104317684 @default.
• W2074784562 hasConcept C143065580 @default.
• W2074784562 hasConcept C144647389 @default.
• W2074784562 hasConcept C170493617 @default.
• W2074784562 hasConcept C185592680 @default.
• W2074784562 hasConcept C24530287 @default.
• W2074784562 hasConcept C2778256703 @default.
• W2074784562 hasConcept C2779030066 @default.
• W2074784562 hasConcept C28005876 @default.
• W2074784562 hasConcept C37113945 @default.
• W2074784562 hasConcept C41625074 @default.
• W2074784562 hasConcept C54355233 @default.
• W2074784562 hasConcept C55493867 @default.
• W2074784562 hasConcept C79747257 @default.

• next